- Bone marrow involvement by primary oxalosis
-
Fratoni S, Niscola P
- KMID: 2509956
- Blood Res.
- 2020 Dec;55(4):192-192.
- doi: 10.5045/br.2020.2020156
-
- CITED
-
- Close
- SHARE
-
- Close
- COVID-19 in a patient with chronic myelomonocytic leukemia: a twisting tale
-
Jain A, Jain A, Prasad P, Chaudhry S, Sharma M, Khunger JM, Gupta DK, Saluja S
- KMID: 2509967
- Blood Res.
- 2020 Dec;55(4):278-281.
- doi: 10.5045/br.2020.2020230
-
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes of patients with essential thrombocythemia and unnoticed thrombocytosis prior to diagnosis
-
Lee MW, Ryu H, Song IC, Lee HJ, Yun HJ, Jo DY
- KMID: 2509968
- Blood Res.
- 2020 Dec;55(4):281-282.
- doi: 10.5045/br.2020.2020239
-
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary embolism rate in patients infected with SARS-CoV-2
-
Capaccione KM, Li G, Salvatore MM
- KMID: 2509966
- Blood Res.
- 2020 Dec;55(4):275-278.
- doi: 10.5045/br.2020.2020168
-
- CITED
-
- Close
- SHARE
-
- Close
- The detection of Howell-Jolly body-like inclusions in a case of coronavirus disease-2019 (COVID-19)
-
Alisjahbana B, Huang I, Oehadian A
- KMID: 2509955
- Blood Res.
- 2020 Dec;55(4):191-191.
- doi: 10.5045/br.2020.2020186
-
- CITED
-
- Close
- SHARE
-
- Close
- Safety and efficacy analysis of ibrutinib in 32 patients with CLL and various B-cell lymphomas: real-world data from a single-center study in Turkey
-
Göçer M, Kurtoğlu E
- KMID: 2509959
- Blood Res.
- 2020 Dec;55(4):206-212.
- doi: 10.5045/br.2020.2020158
Background Ibrutinib is an oral irreversible Bruton’s tyrosine kinase inhibitor. Here, we demonstrate the efficacy and safety of ibrutinib using real-life data from patients with marginal zone lymphoma (MZL), diffuse large... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic value of TNF-α-308 and IFN-γ-874 single nucleotide polymorphisms and their plasma levels in patients with aplastic anemia
-
Shukla S, Tripathi AK, Prasad Verma S, Awasthi N
- KMID: 2509957
- Blood Res.
- 2020 Dec;55(4):193-199.
- doi: 10.5045/br.2020.2020009
Background Aplastic anemia (AA), an unusual hematological disease, is characterized by hypoplasia of the bone marrow and failure to form blood cells of all three lineages resulting in pancytopenia. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Mining of mortality-related findings in rare bleeding disorders: a retrospective study from two centers
-
Rafieemehr H, Dorgalaleh A, Mansouritorghabeh H
- KMID: 2509960
- Blood Res.
- 2020 Dec;55(4):213-216.
- doi: 10.5045/br.2020.2020023
Background Rare bleeding disorders include inherited coagulation disorders except for von Willebrand disease and hemophilia A and B. These disorders affect both men and women worldwide and mainly have an autosomal... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiotherapy for non-gastric intestinal versus gastric MALT lymphoma: a comparison of treatment outcomes
-
Watanabe S, Ogino I, Hata M
- KMID: 2509958
- Blood Res.
- 2020 Dec;55(4):200-205.
- doi: 10.5045/br.2020.2020174
Background Radiotherapy is often used for treating patients with gastric mucosa-associated lymphoid tissue (MALT) lymphomas who fail to respond to Helicobacter pylori eradication. However, non-gastric intestinal MALT lymphoma is rare, and no... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era
-
Choi S, Kim BK, Ahn HY, Hong KT, Choi JY, Shin HY, Kang HJ
- KMID: 2509961
- Blood Res.
- 2020 Dec;55(4):217-224.
- doi: 10.5045/br.2020.2020127
Background Acute myeloid leukemia (AML) with internal tandem duplication in FMS-like tyrosine kinase 3 (FLT3-ITD) is associated with poor outcomes. This study aimed to analyze the outcomes of pediatric AML patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Changing the frequency and spectra of chromosomal aberrations in Korean patients with acute leukemia in a tertiary care hospital
-
Park JH, Kang MG, Kim HR, Lee YE, Lee JH, Choi HJ, Shin JH, Shin MG
- KMID: 2509962
- Blood Res.
- 2020 Dec;55(4):225-245.
- doi: 10.5045/br.2020.2020255
Background Chromosomal analysis is essential for the diagnosis and risk stratification of all leukemia patients. Not surprisingly, racial differences in chromosomal aberrations (CA) in hematological malignancies could be found, and CA... -
- CITED
-
- Close
- SHARE
-
- Close
- First report of the unique expression of RECAF (receptor for alfa feto-protein) in adult B-NHL/CLL patients
-
Adel Sedky H, Youssef SR, Gamal DA, Houssein HF, Elsalakawy WA
- KMID: 2509964
- Blood Res.
- 2020 Dec;55(4):253-261.
- doi: 10.5045/br.2020.2020070
Background Lymphoproliferative disorders (LPDs) are a heterogeneous group of diseases characterized by an uncontrolled production of monoclonal lymphocytes. RECAF is the receptor for alpha-fetoprotein, which is re-expressed on malignant cells, thus... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and effectiveness of Rixubis in patients with hemophilia B: a real-world, prospective, postmarketing surveillance study in South Korea
-
Choi EJ, Hwang Tj, Choi YM, Kim HC, Yoo MC, Song H, Badejo K
- KMID: 2509963
- Blood Res.
- 2020 Dec;55(4):246-252.
- doi: 10.5045/br.2020.2020225
Background Rixubis (recombinant factor IX, nonacog gamma) is indicated for the control and prevention of bleeding episodes, perioperative management, and routine prophylaxis in hemophilia B patients. This real-world, postmarketing surveillance study... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term treatment outcomes of children and adolescents with lymphoblastic lymphoma treated with various regimens:a single-center analysis
-
Choi HJ, Shin J, Kang S, Suh JK, Kim H, Koh KN, Im HJ
- KMID: 2509965
- Blood Res.
- 2020 Dec;55(4):262-274.
- doi: 10.5045/br.2020.2020220
Background Lymphoblastic lymphoma (LBL) is the second most common subtype of pediatric non-Hodgkin lymphoma. Modified treatments derived from the LSA2-L2 regimen resulted in encouraging survival, but toxicities and long-term sequelae have... -
- CITED
-
- Close
- SHARE
-
- Close
